Fertility testing is a physical and medical assessments that test the ability of both male and female to naturally conceive, get pregnant, and have kids. There are number of fertility test available for both male and female. The fertility tests for women includes chlamydia test, blood tests, ultrasound scan, X-ray, urine, saliva test and many others. The fertility tests for men includes genetic testing, semen analysis, chlamydia test, antisperm antibody testing and many others. To perform these testing number of fertility test kits are available in the market.
The Asia Pacific fertility test market is witnessing fastest growth from the past few years. The countries such as the China, India and Japan have dominated the market in the 2020. The growing market for healthcare sector across the region, increasing number of hospitals, fertility clinics and research centers across the countries such as China and India, growing and entry of major medical device manufacturers are major driving factors behind the market growth in the country. Likewise, factors such as increasing popularity for e-pharmacies and e-shopping platforms across the region, also rising preference of the consumers towards over-the-counter fertility test products and surged launch of various fertility test technologies by global market players in developing countries are expected to improve growth of the market in the coming years.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the fertility test market. In addition, complete analysis of changes on fertility test market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Increased number of couple who planned pregnancy during the COVID-19 pandemic has created more demand for fertility testing kits or products, this has affected positively on the market.
The study analyses Asia Pacific fertility test market based on product, mode of purchase, application, end user, and country.
Various products such as ovulation prediction kits, fertility monitors, and male fertility testing products are covered in the Asia Pacific fertility test market report. The ovulation prediction kits (OPKs) segment dominated the Asia Pacific fertility test market in 2020. The ovulation prediction kits are more accurate than any other procedures of detecting ovulation and are approximately 85-97% effective in the detection of luteinizing hormone (LH) surge. OPKs are readily available at most pharmacies and drugstores. No prescription is required to buy an ovulation test kit. This make them more demandable in the global market. Alternatively, the fertility monitors segment is further bifurcated into urine-based ovulation kits, saliva-based ovulation kits, blood-based ovulation kits and other fertility monitors.
Based on mode of purchase, the market is segmented into direct/prescription-based products, OTC-based products and online products. The direct or prescription-based fertility test products requires doctor’s prescription. Over-the-counter fertility test products does not require prescription, they can be easily buy from medication shops, retail pharmacies and any other means. And through the online means a user can buy both prescribed as well as non-prescribed fertility test products. The OTC-based products segment is likely to witness rapid growth in the coming years.
The Asia Pacific fertility test market finds applications in female fertility products and male fertility products. The female fertility product segment dominated the market in 2020 and is expected to maintain its dominance during the estimation period. The massive availability of several fertility test or treatment options and products, the rising awareness among women regarding advanced fertility treatments, and the growing number of fertility clinics for women are major factors driving the growth of the female fertility application segment.
The end users covered in Asia Pacific fertility test market are home care settings, hospitals and fertility clinics and other end users. Home care setting segment is anticipated to witness fastest growth in the near future. The others end users includes laboratories, research centers, and academic institutes. An increasing research and development activities by researchers or scientists in the field of both male and female fertility tests is flourishing the growth of the market across the region.
Country wise, the study is comprised of the key countries such as China, India, Japan and rest of Asia Pacific. China held the largest market share of APAC fertility test market and is likely to dominate the market over the estimated time frame. Increase in disposable income, good repayment schemes by the governmental bodies in the country, higher healthcare spending, and growing population, adoption of high-end medical technology, growth in the fertility clinics in India and rising research and development and growth in healthcare expenditures are major factors that attributed to the market growth in the APAC region.
The major key players of market includes Advacare Pharma, Ava, Babystart (Snowden Healthcare), Biozhena, Church & Dwight, Exseed Health, Fairhaven Health, Fertility Focus, Geratherm Medical, Hilin Life Products, Medical Electronic Systems, Mira Care, Pregmate, Prestige Brands Holdings, Sensiia, Swim Count (Subsidiary Of Motiltycount Aps), Swiss Precision Diagnostics, Tempdrop, Uebe Medical and Valley Electronics among others.
The study analyses Asia Pacific fertility test market based on purchase, application, end user, and country. Fertility Test market by product is segmented into ovulation prediction kits, fertility monitors, and male fertility testing products. The ovulation prediction kits segment is likely to dominate the market over the forecast period. Increased adoption of ovulation prediction kits owing to its several benefits such as low cost is attributed to the market growth. By mode of purchase, the market is segmented into direct/prescription-based products, OTC-based products, and online products. The market finds application in female fertility products and male fertility products. The female fertility products segment is likely to register fastest growth in years to come owing to the growing adoption of female fertility products owing to its easy availability. By mode of end user, the market is segmented into home care settings, hospitals and fertility clinics and other end users. Country wise, the study is comprised of the key countries such as China, India, Japan and rest of Asia Pacific.
Why to buy this report: